Neurotech Pharmaceuticals Adds Ophthalmology Experts to Board of Directors

Neurotech Pharmaceuticals has expanded its board of directors to include several ophthalmology experts — Eugene de Juan, Jr., MD, and Lester Kaplan, PhD.

Advertisement

Rhett Schiffman, MD, former Allergan vice president and therapeutic area head for ophthalmology, has also joined the company.

Dr. de Juan is a retinal surgeon, inventor and entrepreneur. He is the vice chairman of ForSight labs. Dr. Kaplan is the former executive vice president and president of research and development and a board member of Allergan.  

More Articles on Ophthalmology:
5 Ways Healthcare Reform Will Impact Ophthalmologists
Ophthalmic Laser Company Lumenis Receives FDA 510(k) Approval
Ophthalmologist Dr. Benjamin Hale Joins Geisinger Health System in Pennsylvania

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Register to Attend Webinar

Unlocking Structural Heart Capacity: How Leading Programs Use EMR and Data to Improve Patient Flow and Throughput

Wednesday, August 19
11:00 AM - 12:00 PM CDT

Presenters: Katie Kennedy, MSN, APRN, NP-C, Community Heart and VascularMisty Theriot, BSN, RN, CPHQ, FACC, Lake Charles Memorial Health SystemKatie Worthington, DNP, RN, Atlantic Health SystemTaryn Shipley, MBA, CSSBB, Lean HealthTech

Advertisement

Next Up in Ophthalmology

Advertisement

Comments are closed.